The Replica project has established a fruitful partnership with universities and research centers from different geopolitical regions supporting in vitro inter-laboratory studies on Tobacco Harm Reduction and investigating reduced risk product (RRPs) safety compared to combustible cigarettes.
Faculty of Medical Sciences, University of Kragujevac
Medical doctor with PhD and residency in Immunology, he possesses a unique combination of academic knowledge in Immunology and Stem Cell Science enabling him to conduct research in immunology, drug discovery, molecular biology, bioengineering, stem cell science and translational medicine.
Institute of Research and Development NOSMOKE.TEAM Greece
Konstantinos Poulas studied biology at the University of Athens where he also completed his Ph.D. He has been faculty member of the Department of Pharmacy at the University of Patras. He has more than 80 publications in peer reviewed journals and he is currently participating in HORIZON2020 and national projects.
Ronny is graduated as Medical Doctor from Faculty of Medicine and Master of Health Science in 2006. He got a promotion as Assistant Professor in 2015 and to be Associate Professor in 2019. He had continue his PhD study in endocrinology and exercise in Gunma University Graduate Medical School Japan.
Sultan Qaboos University
Dr. Fahad AL Zadjali has obtained PhD degree in Medical Science in 2011 from
Karolinska Institutet, Sweden. Currently Dr. Al-Zadjali is an assistant professor at Department of Biochemistry ,College of Medicine & Health Science, at the Sultan Qaboos University and also the deputy director of Medical Research Center at the University.
Antonio Giordano is an Italian-American oncologist, pathologist, genetist, researcher, professor, and writer. Dr. Giordano is the President & Founder of the Sbarro Health Research Organization (www.shro.org), Director and Professor of the Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology at Temple University, College of Science & Technology in Philadelphia.
Thanks to the cooperation of a network of 7 independent laboratories worldwide, coordinated by the CoEHAR, the Replica team has defined its scientific research on ECIG and HTP through compliance to regulatory standards and open science principles.
A new phase of research for Replica has started!